WHO ICTRP trial
Multi-center Study of IFN combined with Nucleosides analog antiviral therapy in…
ChiCTR2000038674 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000038674 |
|---|---|
| Public title | Multi-center Study of IFN combined with Nucleosides analog antiviral therapy in pediatric patients with HBeAg positive Chronic Hepatitis B (CHB) aged 1-16 years |
| Scientific title | Multi-center Study of IFN combined with Nucleosides analog antivirus therapy in 1-16 years pediatric patients with HBeAg positive Chronic Hepatitis B (CHB) Patients |
| Primary sponsor | The fifth medical center of the General Hospital of the people's Liberation Army of China |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | HBeAg positive Chronic Hepatitis B |
| Interventions | Experimental:Drug (NAs + IFN for 96 weeks);Control group:Drug (NAs for 48 weeks, then NAs combined with IFN for 96 weeks) |
| Registration date | Sep 27, 2020 |
| Target size | Experimental:100;Control group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: